全球气体交换肺功能测试市场

预计到 2030 年全球气体交换肺功能测试市场规模将达到 3.194 亿美元

全球气体交换肺功能测试市场规模预计在2024年为2.448亿美元，预计2030年将达到3.194亿美元，2024年至2030年的复合年增长率为4.5%。可携式系统是本报告分析的细分市场之一，预计其复合年增长率为5.4%，到分析期结束时规模将达到2.087亿美元。固定式系统细分市场在分析期间的复合年增长率预计为3.0%。

美国市场规模估计为 6,670 万美元，中国市场预计复合年增长率为 8.4%

美国气体交换肺功能测试市场规模预计在2024年达到6,670万美元。作为世界第二大经济体，中国预计在2030年市场规模将达到6,680万美元，2024年至2030年的复合年增长率为8.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.8%和3.6%。在欧洲，预计德国的复合年增长率为2.7%。

全球气体交换肺功能测试市场—主要趋势与驱动因素摘要

为什么气体交换肺功能测试在呼吸健康管理中很重要？

气体交换肺功能测试 (PFT) 在评估肺功能方面发挥重要作用，它可以测量氧气和二氧化碳在肺部和血液之间的传输效率。这些检查对于诊断和治疗呼吸系统疾病（例如慢性阻塞性肺病(COPD)、气喘、肺纤维化和间质性肺病）至关重要。最常见的气体交换测试包括肺部一氧化碳扩散能力 (DLCO) 和动脉血气 (ABG) 分析，它们为了解肺部健康和氧合效率提供了重要资讯。这些测试有助于医生确定疾病严重程度、监测病情进展并评估治疗方案的有效性。

由于空气污染、吸烟、职业危害以及新冠肺炎 (COVID-19) 的长期影响等因素，呼吸系统疾病的盛行率不断上升，这加剧了对肺功能检测的需求。医院、诊所和诊断实验室正在投资先进的气体交换检测设备，以改善早期疾病检测和个人化治疗策略。此外，携带式肺功能测试 (PFT) 设备和非侵入性监测工具等技术进步正在扩大肺功能评估的可近性，尤其是在偏远和服务不足的地区。随着全球呼吸健康问题日益严重，气体交换肺功能测试仍将是呼吸照护和疾病预防的基石。

肺功能检测技术主要有哪些进展？

肺功能测试领域取得了显着的技术进步，提高了准确性、效率和患者舒适度。其中最具影响力的创新之一是数位肺量计和体积描记系统的开发，它们能够提供更准确的即时肺功能数据。这些系统整合了人工智慧主导的分析技术，以识别肺功能的模式，帮助更早诊断疾病并推荐个人化治疗方案。此外，穿戴式呼吸监测设备的采用使得能够持续追踪慢性呼吸系统疾病患者的肺功能。

非侵入式可携式气体交换检测解决方案也正在改变肺部诊断，使医疗保健提供者能够在传统医院环境之外进行检测。家用肺功能测试 (PFT) 设备在慢性肺病患者中越来越受欢迎，它们不仅方便患者使用，还能与医疗保健专业人员即时共用数据。远端医疗与肺功能测试的整合进一步增强了远距患者管理，使医生无需亲自就诊即可监测肺部健康状况。随着医疗保健系统持续拥抱数位转型，肺功能测试技术的进步有望改善疾病的早期发现和患者预后。

哪些因素推动了气体交换肺功能测试市场的扩张？

气体交换肺功能测试市场的成长受到多种因素的推动，包括呼吸系统疾病负担的增加、诊断技术的进步以及医疗保健支出的增加。由于环境污染、吸烟和职业危害，全球慢性阻塞性肺病 (COPD)、气喘和肺纤维化的盛行率正在急剧上升，因此需要进行广泛的肺功能评估。老年人口更容易患呼吸系统疾病，因此定期进行肺功能测试的需求也随之增加。

数位健康解决方案和人工智慧诊断技术的采用也推动了市场成长，医疗保健提供者利用智慧呼吸监测工具进行早期疾病检测和优化治疗。此外，政府为提高肺部健康意识和开展筛检计画而推出的措施正在扩大肺功能检测的可近性。远端医疗服务与携带式诊断设备的日益融合，进一步促进了远端肺功能监测，尤其是在农村和服务欠缺地区。随着技术进步不断重塑呼吸诊断，预计气体交换肺功能检测市场将持续成长，这主要得益于技术创新、不断增长的医疗需求以及对准确、即时肺功能评估的需求。

部分

系统类型（可携式系统、固定式系统）、测试方法（气体扩散测试、心肺运动测试）、应用（慢性阻塞性肺病应用、气喘应用、慢性呼吸急促应用、肺纤维化应用、其他应用）、最终用途（医院/诊所最终用途、诊断中心最终用途、其他最终用途）

受访公司范例

• 4DMedical
• CHEST MI, Inc.
• COSMED Srl
• ECO MEDICS AG
• Ganshorn Medizin Electronic
• Hocoma
• KoKo PFT
• Koninklijke Philips NV
• Medical Electronic Construction
• Medical Equipment Europe GmbH
• Medical Technologies
• Medipines
• MGC Diagnostics Corporation
• Minato Holdings Inc.
• Morgan Scientific Inc.
• ndd Medizintechnik AG
• NSPIRE HEALTH INC.
• PulmOne Advanced Medical Devices
• Schiller AG
• Vyaire Medical, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Gas Exchange Pulmonary Function Testing Market to Reach US$319.4 Million by 2030

The global market for Gas Exchange Pulmonary Function Testing estimated at US$244.8 Million in the year 2024, is expected to reach US$319.4 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Portable System, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$208.7 Million by the end of the analysis period. Growth in the Stationary System segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$66.7 Million While China is Forecast to Grow at 8.4% CAGR

The Gas Exchange Pulmonary Function Testing market in the U.S. is estimated at US$66.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$66.8 Million by the year 2030 trailing a CAGR of 8.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Gas Exchange Pulmonary Function Testing Market - Key Trends & Drivers Summarized

Why Is Gas Exchange Pulmonary Function Testing Crucial in Respiratory Health Management?

Gas exchange pulmonary function testing (PFT) plays a vital role in assessing lung function, measuring how efficiently oxygen and carbon dioxide are transferred between the lungs and bloodstream. These tests are essential for diagnosing and managing respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and interstitial lung diseases. The most common gas exchange tests include the diffusing capacity of the lungs for carbon monoxide (DLCO) and arterial blood gas (ABG) analysis, which provide crucial insights into lung health and oxygenation efficiency. These tests help physicians determine disease severity, monitor disease progression, and evaluate the effectiveness of treatment plans.

The increasing prevalence of respiratory diseases, driven by factors such as air pollution, smoking, occupational hazards, and the long-term impact of COVID-19, has amplified the demand for pulmonary function testing. Hospitals, clinics, and diagnostic laboratories are investing in advanced gas exchange testing equipment to improve early disease detection and personalized treatment strategies. Furthermore, technological advancements such as portable PFT devices and non-invasive monitoring tools have expanded accessibility to lung function assessments, particularly in remote or underserved regions. As global respiratory health concerns continue to rise, gas exchange pulmonary function testing remains a cornerstone of respiratory care and disease prevention.

What Are the Key Developments in Pulmonary Function Testing Technology?

The field of pulmonary function testing has witnessed significant technological advancements, enhancing accuracy, efficiency, and patient comfort. One of the most impactful innovations is the development of digital spirometry and plethysmography systems, which provide real-time lung function data with greater precision. These systems integrate AI-driven analytics to identify patterns in lung function, aiding in early disease diagnosis and personalized treatment recommendations. Additionally, the adoption of wearable respiratory monitoring devices has enabled continuous tracking of lung function in patients with chronic respiratory conditions.

Non-invasive and portable gas exchange testing solutions are also transforming pulmonary diagnostics, allowing healthcare providers to conduct tests outside traditional hospital settings. Home-based PFT devices are gaining popularity among patients with chronic lung diseases, offering convenience and real-time data sharing with healthcare professionals. The integration of telemedicine with pulmonary function testing has further enhanced remote patient management, enabling physicians to monitor lung health without requiring in-person visits. As healthcare systems continue to embrace digital transformation, the evolution of pulmonary function testing technologies is expected to improve early disease detection and patient outcomes.

Which Factors Are Driving the Expansion of the Gas Exchange Pulmonary Function Testing Market?

The growth in the gas exchange pulmonary function testing market is driven by several factors, including the rising burden of respiratory diseases, advancements in diagnostic technologies, and increased healthcare expenditure. The global prevalence of COPD, asthma, and pulmonary fibrosis has surged due to environmental pollutants, smoking, and occupational hazards, necessitating widespread lung function assessments. The aging population is another significant factor, as elderly individuals are more susceptible to respiratory conditions, driving demand for routine pulmonary function testing.

The adoption of digital health solutions and AI-powered diagnostics is also accelerating market growth, with healthcare providers leveraging smart respiratory monitoring tools for early disease detection and treatment optimization. Additionally, government initiatives promoting lung health awareness and screening programs have expanded the accessibility of pulmonary function tests. The increasing integration of telehealth services and portable diagnostic devices has further facilitated remote lung function monitoring, particularly in rural and underserved regions. As technological advancements continue to reshape respiratory diagnostics, the gas exchange pulmonary function testing market is expected to witness sustained growth, driven by innovation, rising healthcare needs, and the demand for precise, real-time lung function assessments.

SCOPE OF STUDY:

The report analyzes the Gas Exchange Pulmonary Function Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

System Type (Portable System, Stationary System); Test Method (Gas Diffusion Tests, Cardiopulmonary Exercise Testing); Application (Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application, Other Applications); End-Use (Hospitals & Clinics End-Use, Diagnostic Centers End-Use, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• 4DMedical
• CHEST M.I., Inc.
• COSMED Srl
• ECO MEDICS AG
• Ganshorn Medizin Electronic
• Hocoma
• KoKo PFT
• Koninklijke Philips N.V.
• Medical Electronic Construction
• Medical Equipment Europe GmbH
• Medical Technologies
• Medipines
• MGC Diagnostics Corporation
• Minato Holdings Inc.
• Morgan Scientific Inc.
• ndd Medizintechnik AG
• NSPIRE HEALTH INC.
• PulmOne Advanced Medical Devices
• Schiller AG
• Vyaire Medical, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Gas Exchange Pulmonary Function Testing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Prevalence of Respiratory Diseases Spurs Demand for Gas Exchange Pulmonary Function Tests
  • Increasing Adoption of Preventive Healthcare and Early Diagnosis Drives Pulmonary Testing Volumes
  • Growth in Geriatric Population Strengthens Long-Term Demand for Lung Function Monitoring Tools
  • Expansion of Respiratory Care Facilities and Pulmonology Clinics Fuels Equipment Procurement
  • Technological Advancements in Sensor Precision and Software Analytics Enhance Test Accuracy and Adoption
  • Wider Availability of Portable and Point-of-Care Testing Devices Expands Access to Lung Function Assessment
  • Increased Use of Gas Exchange Metrics in Athletic and Performance Medicine Drives Clinical Applications
  • Integration with Electronic Medical Records (EMR) Systems Supports Streamlined Clinical Workflows
  • Demand for Real-Time Testing in Critical Care Units Drives Innovation in Bedside Pulmonary Function Tools
  • Increased R&D Investment in Non-Invasive Respiratory Diagnostics Spurs Device Miniaturization
  • Adoption of Telehealth and Remote Monitoring Expands Reach of Home-Based Pulmonary Function Testing
  • Growing Awareness of Occupational Lung Disorders Spurs Routine Screening in Industrial Settings
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Gas Exchange Pulmonary Function Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Portable System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Portable System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Portable System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Stationary System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Stationary System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Stationary System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Gas Diffusion Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Gas Diffusion Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Gas Diffusion Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiopulmonary Exercise Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiopulmonary Exercise Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Cardiopulmonary Exercise Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Chronic Obstructive Pulmonary Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Chronic Obstructive Pulmonary Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Chronic Shortness of Breath Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Chronic Shortness of Breath Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Chronic Shortness of Breath Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pulmonary Fibrosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pulmonary Fibrosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Pulmonary Fibrosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Japan 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 77: China Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: China 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 104: France Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: France 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Germany 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Italy 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 140: UK Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: UK 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Spain 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Russia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Australia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 215: India Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: India 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: South Korea 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Argentina 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Brazil 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Mexico 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 328: Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 340: Iran 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 352: Israel 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 376: UAE 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Gas Exchange Pulmonary Function Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Gas Exchange Pulmonary Function Testing by System Type - Portable System and Stationary System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Gas Exchange Pulmonary Function Testing by System Type - Percentage Breakdown of Value Sales for Portable System and Stationary System for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Gas Exchange Pulmonary Function Testing by End-Use - Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Gas Exchange Pulmonary Function Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Diagnostic Centers End-Use and Other End-Users for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Gas Exchange Pulmonary Function Testing by Test Method - Gas Diffusion Tests and Cardiopulmonary Exercise Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Test Method - Percentage Breakdown of Value Sales for Gas Diffusion Tests and Cardiopulmonary Exercise Testing for the Years 2015, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Gas Exchange Pulmonary Function Testing by Application - Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 400: Africa 15-Year Perspective for Gas Exchange Pulmonary Function Testing by Application - Percentage Breakdown of Value Sales for Chronic Obstructive Pulmonary Disease Application, Asthma Application, Chronic Shortness of Breath Application, Pulmonary Fibrosis Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION